For instance, several pharmaceutical companies are buying developing psychedelics as prescription medicines.82 Examples of this increasing desire include the breakthrough therapy designation granted by the US Foodstuff and Drug Administration to the trials of psilocybin for main melancholy funded from the Usona Institute and for therapy-resistant depression funded by Compass https://www.evernote.com/shard/s719/sh/330863cc-f66e-28c9-1f41-da0804b81796/RMpoTb0riW3RmWT16RjoS367Hafssl_5BT2tyYmOPBlf01wp-Yuv0jPVlw